The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).
Mark R. Gilbert
Consultant or Advisory Role - EMD Serono; Genentech; Merck; Novartis
Honoraria - EMD Serono; Genentech; Merck; Novartis
Research Funding - Genentech; GlaxoSmithKline; Merck
James Dignam
No relevant relationships to disclose
Minhee Won
No relevant relationships to disclose
Deborah T. Blumenthal
No relevant relationships to disclose
Michael A. Vogelbaum
Honoraria - Merck
Kenneth D. Aldape
No relevant relationships to disclose
Howard Colman
Consultant or Advisory Role - Castle Biosciences; Roche/Genentech
Arnab Chakravarti
No relevant relationships to disclose
Robert Jeraj
No relevant relationships to disclose
Terri S. Armstrong
Research Funding - Genentech
Jeffrey Scott Wefel
Consultant or Advisory Role - Roche/Genentech
Paul D. Brown
No relevant relationships to disclose
Kurt A. Jaeckle
No relevant relationships to disclose
David Schiff
Consultant or Advisory Role - Genentech
James Norman Atkins
No relevant relationships to disclose
David Brachman
No relevant relationships to disclose
Maria Werner-Wasik
No relevant relationships to disclose
Ritsuko Komaki
No relevant relationships to disclose
Erik P. Sulman
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - Merck
Minesh P. Mehta
Consultant or Advisory Role - Genentech; Merck
Stock Ownership - Accuray
Honoraria - Merck